Coherus Oncology, Inc. (CHRS) Stock Price History
Historical prices from 2014 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
CHRS Stock Price Trajectory (2014–2026)
As of March 1, 2026, Coherus Oncology, Inc. (CHRS) trades at $1.67, representing a +50.5% return over the past year. The stock has delivered a -36.4% return over five years, reflecting challenging market conditions.
The stock reached its all-time high of $38.10 on July 22, 2015. From this peak, CHRS has corrected -95.6%, currently trading 27% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers RVMD (+150.4% 1Y), INCY (+37.8% 1Y), and GMAB (+29.8% 1Y), CHRS has underperformed the peer group average. Compare CHRS vs RVMD →
Historical Price Data
Showing 30 of 2,844 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-02-27 | 1.65 | 1.69 | 1.65 | 1.67 | 1 | -1.18% |
| 2026-02-26 | 1.67 | 1.70 | 1.63 | 1.69 | 1 | +0.60% |
| 2026-02-25 | 1.68 | 1.74 | 1.66 | 1.68 | 1 | +0.60% |
| 2026-02-24 | 1.64 | 1.70 | 1.62 | 1.67 | 1 | +3.09% |
| 2026-02-23 | 1.62 | 1.65 | 1.59 | 1.62 | 1 | -0.61% |
| 2026-02-20 | 1.70 | 1.73 | 1.62 | 1.63 | 1 | -4.68% |
| 2026-02-19 | 1.61 | 1.73 | 1.60 | 1.71 | 2.35M | +4.91% |
| 2026-02-18 | 1.62 | 1.66 | 1.60 | 1.63 | 1.83M | -0.91% |
| 2026-02-17 | 1.71 | 1.71 | 1.61 | 1.65 | 258K | +2.17% |
| 2026-02-13 | 1.70 | 1.79 | 1.58 | 1.61 | 10.92M | -19.90% |
| 2026-02-12 | 2.06 | 2.07 | 1.98 | 2.01 | 870K | -1.47% |
| 2026-02-11 | 2.11 | 2.12 | 1.97 | 2.04 | 886K | -3.32% |
| 2026-02-10 | 2.07 | 2.20 | 2.05 | 2.11 | 804K | +2.43% |
| 2026-02-09 | 2.13 | 2.16 | 1.95 | 2.06 | 1.48M | -3.74% |
| 2026-02-06 | 2.15 | 2.19 | 2.02 | 2.14 | 2.44M | +2.39% |
| 2026-02-05 | 2.20 | 2.24 | 2.07 | 2.09 | 1.69M | -5.86% |
| 2026-02-04 | 2.28 | 2.42 | 2.18 | 2.22 | 2.07M | 0.00% |
| 2026-02-03 | 2.18 | 2.25 | 2.10 | 2.22 | 1.67M | +2.30% |
| 2026-02-02 | 2.13 | 2.31 | 2.11 | 2.17 | 1.80M | +0.46% |
| 2026-01-30 | 2.30 | 2.37 | 2.13 | 2.16 | 1.92M | -7.30% |
| 2026-01-29 | 2.19 | 2.39 | 2.08 | 2.33 | 2.25M | +5.19% |
| 2026-01-28 | 2.51 | 2.57 | 2.21 | 2.21 | 3.42M | -11.75% |
| 2026-01-27 | 2.31 | 2.62 | 2.17 | 2.51 | 8.83M | +10.09% |
| 2026-01-26 | 2.02 | 2.30 | 2.00 | 2.28 | 7.54M | +10.68% |
| 2026-01-24 | 1.86 | 2.17 | 1.83 | 2.06 | 21.00M | 0.00% |
| 2026-01-23 | 1.86 | 2.17 | 1.83 | 2.06 | 21.61M | +29.56% |
| 2026-01-22 | 1.64 | 1.67 | 1.57 | 1.59 | 2.77M | -3.05% |
| 2026-01-21 | 1.56 | 1.64 | 1.55 | 1.64 | 842K | +5.81% |
| 2026-01-20 | 1.56 | 1.61 | 1.51 | 1.55 | 1.26M | -3.13% |
| 2026-01-16 | 1.67 | 1.67 | 1.59 | 1.60 | 985K | -3.61% |
See CHRS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CHRS Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare CHRS vs AGIO
See how CHRS stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How has CHRS stock performed recently?
CHRS returned +50.5% over the past year, beating its 5-year annualized CAGR of -36.4%. The stock trades above its 200-day moving average, confirming the uptrend.
What is CHRS's all-time high price?
Coherus Oncology, Inc. reached $38.10 on 2015-07-22. The 52-week high is $2.62. Current 1-year return of +50.5% places the stock closer to historical peaks.
Where can I download CHRS historical price data?
This page provides CHRS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2014-2026, downloadable in CSV format.